VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors

BACKGROUND: As a proteoglycan, VCAN exists in the tumor microenvironment and regulates tumor proliferation, invasion, and metastasis, but its role in hepatocellular carcinoma (HCC) has not yet been elucidated. AIM: To investigate the expression and potential mechanism of action of VCAN in HCC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mu-Qi, Li, Ya-Ping, Xu, Meng, Tian, Yan, Wu, Yuan, Zhang, Xin, Shi, Juan-Juan, Dang, Shuang-Suo, Jia, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611428/
https://www.ncbi.nlm.nih.gov/pubmed/36310697
http://dx.doi.org/10.4251/wjgo.v14.i10.1933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611428/
https://www.ncbi.nlm.nih.gov/pubmed/36310697
http://dx.doi.org/10.4251/wjgo.v14.i10.1933

Ejemplares similares